Exhibits
10-K
from 10-K
156 pages
10-K
03/08/24
EX-10.5
from 10-K
3 pages
Janux Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
03/08/24
EX-10.14
from 10-K
4 pages
January 1, 2021 Thomas Diraimondo Re: Employment Terms Dear Tommy: Janux Therapeutics, Inc. (The "Company") Is Pleased to Offer You Employment Beginning on January 1, 2021 (The "Start Date"). Position
03/08/24
EX-10.22
from 10-K
7 pages
The Compensation Committee (The “Compensation Committee”) of the Board of Directors (The “Board”) of Janux Therapeutics, Inc., a Delaware Corporation (The “Company”), Has Determined That It Is in the Best Interests of the Company and Its Stockholders to Adopt This Incentive Compensation Recoupment Policy (This “Policy”) Providing for the Company’s Recoupment of Recoverable Incentive Compensation That Is Received by Covered Officers of the Company Under Certain Circumstances. Certain Capitalized Terms Used in This Policy Have the Meanings Given to Such Terms in Section 3 Below. This Policy Is Designed to Comply With, and Shall Be Interpreted to Be Consistent With, Section 10d of the Exchange Act, Rule 10d-1 Promulgated Thereunder (“Rule 10d-1”) and NASDAQ Listing Rule 5608 (The “Listing Standards”). 2. Effective Date
03/08/24
EX-23.1
from 10-K
2 pages
Consent of expert or counsel
03/08/24
EX-31.1
from 10-K
2 pages
Management certification of annual or quarterly disclosure
03/08/24
EX-31.2
from 10-K
2 pages
Management certification of annual or quarterly disclosure
03/08/24
EX-32.1
from 10-K
2 pages
Management certification of financial report
03/08/24
Graphics & Data Files
GRAPHIC
from 10-K
img111646922_0.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_1.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_2.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_3.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_4.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_5.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_6.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_7.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_8.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_9.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_10.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_11.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_12.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_13.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_14.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_15.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_16.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_17.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_18.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_19.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_20.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_21.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_22.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_23.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_24.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_25.jpg
03/08/24
GRAPHIC
from 10-K
img111646922_26.jpg
03/08/24
GRAPHIC
from 10-K
img192204503_0.jpg
03/08/24
